Use of a modified alpha-N-acetylgalactosaminidase in the development of enzyme replacement therapy for Fabry disease.
Tajima Y, Kawashima I, Tsukimura T, Sugawara K, Kuroda M, Suzuki T, Togawa T, Chiba Y, Jigami Y, Ohno K, Fukushige T, Kanekura T, Itoh K, Ohashi T, Sakuraba H.
Tajima Y, et al. Among authors: tsukimura t.
Am J Hum Genet. 2009 Nov;85(5):569-80. doi: 10.1016/j.ajhg.2009.09.016. Epub 2009 Oct 22.
Am J Hum Genet. 2009.
PMID: 19853240
Free PMC article.